Drug & medication recalls Moderate risk

Ranitidine 150 mg recalled over manufacturing violations

Recall date
January 15, 2020
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Direct Rx recalls Ranitidine 150 mg, a) 60 Tabs (NDC 61919-339-60); and b) 90 Tabs (NDC 61919-339-90) bottles, Rx only, Packaged and Dist…
Recall number
D-0016-2021
FDA classification
Class II
Brand / firm
Direct Rx
Sold / distributed
FL, GA

Why it was recalled

CGMP Deviations: Presence of NDMA impurity detected in product.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Ranitidine 150 mg, a) 60 Tabs (NDC 61919-339-60); and b) 90 Tabs (NDC 61919-339-90) bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534

Get recall alerts

Free email alert whenever Direct Rx has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Direct Rx